Cochrane · systematic review · CD001751
Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea
Marjoribanks, J, Ayeleke, RO, Farquhar, C, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library
Gynaecology and FertilityAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 1 · 25%Low 3 · 75%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
NSAIDs compared to placebo for dysmenorrhoea
Population: women with primary dysmenorrhoea
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain relief dichotomous data NSAIDs vs placebo | OR 4.37 [3.76, 5.09] | NR | Low Downgraded: risk of bias, imprecision, inconsistency, publication bias |
All adverse effects NSAIDs vs placebo | OR 1.29 [1.11, 1.51] | NR | Low Downgraded: risk of bias, imprecision, publication bias |
NSAIDs compared to paracetamol for dysmenorrhoea
Population: women with primary dysmenorrhoea
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain relief dichotomous data NSAIDs vs paracetamol | OR 1.89 [1.05, 3.43] | NR | Low Downgraded: risk of bias, imprecision |
All adverse effects ‐ ibuprofen versus paracetamol NSAIDs vs paracetamol | OR 0.85 [0.31, 2.34] | NR | Very low Downgraded: risk of bias, imprecision |